Showing results (71-80 of 578) with videos related to
Sort By:
Pageof 58
Acta Neurologica Scandinavica. Supplementum|February 27, 2003
Instrumental activities of daily living: a stepping-stone towards Alzheimer's disease diagnosis in subjects with mild cognitive impairment?Louise NygårdActa Neurologica Scandinavica. Supplementum|February 27, 2003
Cerebrospinal fluid levels of total-tau, phospho-tau and A beta 42 predicts development of Alzheimer's disease in patients with mild cognitive impairmentNiels Andreasen, Eugeen Vanmechelen, Hugo Vanderstichele, et al.Acta Neurologica Scandinavica. Supplementum|February 27, 2003
Clinical findings in nondemented mutation carriers predisposed to Alzheimer's disease: a model of mild cognitive impairmentOve Almkvist, Karin Axelman, Hans Basun, et al.Acta Neurologica Scandinavica. Supplementum|December 21, 2002
Non-cognitive benefits of galantamine (Reminyl) treatment in vascular dementiaA KurzActa Neurologica Scandinavica. Supplementum|March 23, 2001
A pharmacogenomic approach to Alzheimer's diseaseR Cacabelos, A Alvarez, L Fenández-Novoa, et al.Acta Neurologica Scandinavica. Supplementum|March 23, 2001
Galantamine is an allosterically potentiating ligand of the human alpha4/beta2 nAChRM Samochocki, M Zerlin, R Jostock, et al.Acta Neurologica Scandinavica. Supplementum|March 23, 2001
The experimental Alzheimer drug phenserine: preclinical pharmacokinetics and pharmacodynamicsN H Greig, E De Micheli, H W Holloway, et al.Acta Neurologica Scandinavica. Supplementum|January 1, 1995
Recent developments in the epidemiology of epilepsyW A HauserActa Neurologica Scandinavica. Supplementum|January 1, 1995
Pharmacological principles as a basis for polytherapyE PeruccaActa Neurologica Scandinavica. Supplementum|January 1, 1995
Rationalized polytherapy for epilepsyP Goldsmith, P R de BittencourtPageof 58